Lataa...
M112. Clozapine Use in Early-Intervention Programs Across Canada
Background: Clozapine remains to this day the treatment of choice for people with schizophrenia who have failed to respond to 2 consecutive antipsychotic trials. It is estimated that approximately 20% of first-episode psychotic patients fail to respond adequately to 2 consecutive antipsychotic trial...
Tallennettuna:
| Julkaisussa: | Schizophr Bull |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Oxford University Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5476009/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbx022.107 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|